Why Procter & Gamble (PG) Is Getting Attention Today

Procter & Gamble Company

Procter & Gamble Company

PG

0.00

Procter & Gamble (PG) has leaned into seasonal marketing with Charmin’s back to college Forever Roll campaign and Swiffer’s collaboration with hair expert Jen Atkin, spotlighting products tied to everyday household inconveniences.

At a share price of $146.60, Procter & Gamble’s 1-day share price return of 1.33% and 7-day share price return of 2.43% suggest some short-term momentum. The 1-year total shareholder return declined 3.36% and the 5-year total shareholder return is 16.62%, pointing to a steadier long-run picture as campaigns like Charmin’s Forever Roll push for seasonal engagement.

If these product campaigns have you thinking about where else consumer trends could matter for your portfolio, it may be a good moment to uncover 20 top founder-led companies

Bulls see Procter & Gamble’s recent share price lift and seasonal campaigns as proof the brand portfolio still commands a premium. Bears point to the 1 year return decline. Which story do current valuation signals support next?

Most Popular Narrative: 36.3% Overvalued

The leading narrative on Procter & Gamble compares a fair value of $107.52 to the recent $146.60 share price and frames today’s level as materially richer than that estimate.

Procter & Gamble operates within a very competitive environment. However, its higher operating margins and wide moat its a clear sign it still operates with competitive advantages over its competitors as well as it has the capability of raising prices if needed. Also, it''s always good to see that it still returns on its investments (ROIC) double its cost of capital, showing good capitall allocation by management.

According to andre_santos, this fair value rests on a mix of steady revenue growth assumptions, firm margins and disciplined reinvestment that aims to keep returns above the discount rate. Want to see how those moving parts, from revenue pacing to long term profit multiples, are wired together in the valuation model and why they point to that specific fair value band.

Result: Fair Value of $107.52 (OVERVALUED)

However, this overvalued story could shift quickly if Procter & Gamble faces sharper competition that squeezes margins, or if consumer demand for its core brands weakens.

Another View On Procter & Gamble's Valuation

andre_santos’ work points to Procter & Gamble trading well above an estimated fair value of $107.52. Our DCF model comes to a very different conclusion. It values the stock at $196.81 based on future cash flows, which frames today’s $146.60 price as trading at a discount instead.

That gap shows how much results can shift depending on which cash flow path and discount rate you think is more realistic. The real question for you is which set of assumptions about Procter & Gamble’s future earnings power you trust more.

PG Discounted Cash Flow as at Aug 2026
PG Discounted Cash Flow as at Aug 2026

Next Steps

If the mix of confidence and caution around Procter & Gamble leaves you unsure, review the current numbers and weigh both the 1 or more risks and the 1 or more rewards being discussed by investors through the 4 key rewards and 2 important warning signs

Looking For More Investment Ideas Beyond Procter & Gamble?

If Procter & Gamble has sharpened your interest in quality businesses, use this moment to broaden your watchlist with fresh ideas from the Simply Wall St Screener.

  • Target steady wealth building by checking out companies flagged as resilient, lower risk opportunities through the 74 resilient stocks with low risk scores.
  • Hunt for potential value opportunities by reviewing companies that look attractively priced on quality and fundamentals in the 49 high quality undervalued stocks.
  • Spot income opportunities by scanning companies with higher yields that focus on consistency through the 12 dividend fortresses.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.